RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
1.630
-0.070 (-4.12%)
Oct 13, 2025, 12:31 PM EDT - Market open
RedHill Biopharma Market Cap
RedHill Biopharma has a market cap or net worth of $5.43 million as of October 13, 2025. Its market cap has decreased by -55.87% in one year.
Market Cap
5.43M
Enterprise Value
3.01M
1-Year Change
-55.87%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since January 7, 2013, RedHill Biopharma's market cap has decreased from $58.80M to $5.43M, a decrease of -90.77%. That is a compound annual growth rate of -17.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 2.20M | -72.15% |
| Dec 31, 2024 | 7.90M | 68.09% |
| Dec 29, 2023 | 4.70M | -47.78% |
| Dec 30, 2022 | 9.00M | -92.54% |
| Dec 31, 2021 | 120.70M | -57.65% |
| Dec 31, 2020 | 285.00M | 65.51% |
| Dec 31, 2019 | 172.20M | 45.81% |
| Dec 31, 2018 | 118.10M | 34.66% |
| Dec 29, 2017 | 87.70M | -34.06% |
| Dec 30, 2016 | 133.00M | 17.49% |
| Dec 31, 2015 | 113.20M | 31.93% |
| Dec 31, 2014 | 85.80M | 37.28% |
| Dec 31, 2013 | 62.50M | 6.29% |
| Jan 7, 2013 | 58.80M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |